• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜癌中DNA聚合酶ϵ基因热点外切核酸酶结构域突变的特征分析

Characterization of hotspot exonuclease domain mutations in the DNA polymerase ϵ gene in endometrial cancer.

作者信息

Tian Wenjuan, Ji Zhaodong, Wang Jingshu, Meng Jiao, Bi Rui, Ren Yulan, Shan Boer, Yang Gong, Wang Huaying

机构信息

Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

出版信息

Front Oncol. 2022 Oct 12;12:1018034. doi: 10.3389/fonc.2022.1018034. eCollection 2022.

DOI:10.3389/fonc.2022.1018034
PMID:36313640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9596989/
Abstract

OBJECTIVE

This study was aimed to profile hotspot exonuclease domain mutations (EDMs) of the DNA polymerase ϵ gene () in endometrial cancer (EC) and to investigate the effects of EDMs on tumor cell behavior and catalytic activities of Polϵ.

METHODS

sequencing was performed in tumor tissue samples from patients with EC to identify hotspot EDMs. Bioinformatics tools were used to select the potential pathogenic EDMs. The association of EDMs with the clinical outcomes of patients was assessed. EC cells were transfected with wildtype or variants to examine the effects of the EDMs on EC cell behavior, including cell cycle, migration, and invasion. Co-immunoprecipitation was employed to obtain FLAG-tagged wildtype and mutant catalytic subunits of Polϵ, followed by the assessment of polymerase and exonuclease activities.

RESULTS

In addition to previously reported P286R and V411L, R375Q and P452L were identified as novel, and deleterious hotspot EDMs of EC. Patients in EDM group had significantly better clinical outcomes than the rest of the cohort. Compared with wildtype POLE, overexpression of POLE variants promoted cisplatin resistance, G0/G1 cell cycle arrest, and cell migration and invasion in EC cells. Overexpression of POLE variants significantly increased the abundance of 3'-OH and upregulated the expression of DNA mismatch repair genes in HEK293T cells. Compared with wildtype Polϵ, Pol ϵ mutants exhibited undermined polymerase and exonuclease abilities in the presence of mismatched nucleotides in HEK293 cells.

CONCLUSION

We characterized the of hotspot exonuclease domain mutations in the DNA polymerase ϵ gene and identified P286R, V411L, R375Q, and P452L as pathogenic hotspot EDMs in endometrial cancer. These hotspot EDMs are associated with the malignant behavior of endometrial cancer cells and favorable prognosis in patients, suggesting that affects a wide range of cellular processes beyond DNA replication and proofreading.

摘要

目的

本研究旨在分析子宫内膜癌(EC)中DNA聚合酶ϵ基因()的热点外切核酸酶结构域突变(EDMs),并研究EDMs对肿瘤细胞行为及Polϵ催化活性的影响。

方法

对EC患者的肿瘤组织样本进行测序以鉴定热点EDMs。使用生物信息学工具筛选潜在的致病性EDMs。评估EDMs与患者临床结局的相关性。用野生型或变体转染EC细胞,以检测EDMs对EC细胞行为的影响,包括细胞周期、迁移和侵袭。采用免疫共沉淀法获得带FLAG标签的Polϵ野生型和突变型催化亚基,随后评估聚合酶和外切核酸酶活性。

结果

除先前报道的P286R和V411L外,R375Q和P452L被鉴定为EC新的有害热点EDMs。EDM组患者的临床结局明显优于队列中的其他患者。与野生型POLE相比,POLE变体的过表达促进了EC细胞对顺铂的耐药性、G0/G1细胞周期阻滞以及细胞迁移和侵袭。POLE变体的过表达显著增加了3'-OH的丰度,并上调了HEK293T细胞中DNA错配修复基因的表达。与野生型Polϵ相比,在HEK293细胞中存在错配核苷酸的情况下,Pol ϵ突变体表现出受损的聚合酶和外切核酸酶能力。

结论

我们对DNA聚合酶ϵ基因的热点外切核酸酶结构域突变进行了特征分析,并确定P286R、V411L、R375Q和P452L为子宫内膜癌致病性热点EDMs。这些热点EDMs与子宫内膜癌细胞的恶性行为及患者的良好预后相关,表明其影响范围超出了DNA复制和校对的广泛细胞过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d0/9596989/996a90b96bdf/fonc-12-1018034-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d0/9596989/96768fdcebe1/fonc-12-1018034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d0/9596989/339a089a20f4/fonc-12-1018034-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d0/9596989/179938446fde/fonc-12-1018034-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d0/9596989/1900989b3a5c/fonc-12-1018034-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d0/9596989/7981f5b656bb/fonc-12-1018034-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d0/9596989/996a90b96bdf/fonc-12-1018034-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d0/9596989/96768fdcebe1/fonc-12-1018034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d0/9596989/339a089a20f4/fonc-12-1018034-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d0/9596989/179938446fde/fonc-12-1018034-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d0/9596989/1900989b3a5c/fonc-12-1018034-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d0/9596989/7981f5b656bb/fonc-12-1018034-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d0/9596989/996a90b96bdf/fonc-12-1018034-g006.jpg

相似文献

1
Characterization of hotspot exonuclease domain mutations in the DNA polymerase ϵ gene in endometrial cancer.子宫内膜癌中DNA聚合酶ϵ基因热点外切核酸酶结构域突变的特征分析
Front Oncol. 2022 Oct 12;12:1018034. doi: 10.3389/fonc.2022.1018034. eCollection 2022.
2
DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.DNA 聚合酶 ε 和 δ 外切酶结构域突变与子宫内膜癌。
Hum Mol Genet. 2013 Jul 15;22(14):2820-8. doi: 10.1093/hmg/ddt131. Epub 2013 Mar 24.
3
Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis.POLE 外切酶结构域突变的子宫内膜癌具有良好的预后。
Clin Cancer Res. 2016 Jun 15;22(12):2865-73. doi: 10.1158/1078-0432.CCR-15-2233. Epub 2016 Jan 13.
4
The game-changing impact of mutations in oncology-a review from a gynecologic oncology perspective.肿瘤学中突变的变革性影响——从妇科肿瘤学视角的综述
Front Oncol. 2024 Aug 22;14:1369189. doi: 10.3389/fonc.2024.1369189. eCollection 2024.
5
Clinicopathological characteristics and prognostic value of POLE mutations in endometrial cancer: A systematic review and meta-analysis.子宫内膜癌中POLE突变的临床病理特征及预后价值:一项系统评价与Meta分析
Medicine (Baltimore). 2020 Feb;99(8):e19281. doi: 10.1097/MD.0000000000019281.
6
A novel somatic mutation in POLE exonuclease domain associated with ultra-mutational signature and MMR deficiency in endometrial cancer: a case report.POLE 外切酶结构域的新型种系突变与子宫内膜癌中超突变特征和 MMR 缺陷相关:一例报告。
Diagn Pathol. 2023 Feb 10;18(1):19. doi: 10.1186/s13000-023-01287-y.
7
Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer.体细胞 POLE 外切酶结构域突变可在 II 期结直肠癌中引发更强的肿瘤内免疫反应。
J Immunother Cancer. 2020 Aug;8(2). doi: 10.1136/jitc-2020-000881.
8
Distinct clinical pattern of colorectal cancer patients with POLE mutations: A retrospective study on real-world data.携带POLE突变的结直肠癌患者的独特临床模式:一项基于真实世界数据的回顾性研究。
Front Genet. 2022 Nov 21;13:963964. doi: 10.3389/fgene.2022.963964. eCollection 2022.
9
Replicative DNA polymerase mutations in cancer.癌症中的复制性DNA聚合酶突变
Curr Opin Genet Dev. 2014 Feb;24(100):107-13. doi: 10.1016/j.gde.2013.12.005. Epub 2014 Feb 26.
10
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.POLE 突变型子宫内膜样癌患者的临床结局。
Gynecol Oncol. 2020 Jan;156(1):194-202. doi: 10.1016/j.ygyno.2019.10.028. Epub 2019 Nov 19.

引用本文的文献

1
The prognostic implication of polymerase epsilon-mutated endometrial cancer.聚合酶ε突变型子宫内膜癌的预后意义。
Tzu Chi Med J. 2024 Sep 17;37(2):135-144. doi: 10.4103/tcmj.tcmj_120_24. eCollection 2025 Apr-Jun.
2
Functions, interactions and prognostic role of : a bioinformatics analysis.关于……的功能、相互作用及预后作用:一项生物信息学分析 (原文冒号前缺少具体内容)
J Gynecol Oncol. 2025 May;36(3):e45. doi: 10.3802/jgo.2025.36.e45. Epub 2024 Nov 5.
3
Accelerated clinical response achieved by combining short-term tumor-directed photodynamic therapy with immunotherapy-based systemic therapies in synchronous colorectal cancer with MSI-H and POLE mutation: a case report.

本文引用的文献

1
Exploring the Consistency of the Quality Scores with Machine Learning for Next-Generation Sequencing Experiments.探索下一代测序实验中机器学习质量评分的一致性。
Biomed Res Int. 2020 Feb 25;2020:8531502. doi: 10.1155/2020/8531502. eCollection 2020.
2
Interpretation of somatic POLE mutations in endometrial carcinoma.子宫内膜癌中体 POLE 突变的解读。
J Pathol. 2020 Mar;250(3):323-335. doi: 10.1002/path.5372. Epub 2020 Jan 29.
3
Phenotype of POLE-mutated endometrial cancer.POLE 突变型子宫内膜癌的表型。
联合 MSI-H 和 POLE 突变的同步结直肠癌的短期肿瘤导向光动力治疗与基于免疫疗法的系统治疗实现加速临床应答:一例报告。
Front Immunol. 2024 Jun 28;15:1402334. doi: 10.3389/fimmu.2024.1402334. eCollection 2024.
4
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection.子宫内膜癌的分子分类及其对治疗选择的影响。
Int J Mol Sci. 2024 May 28;25(11):5893. doi: 10.3390/ijms25115893.
5
The Clinical and Pathological Characteristics of POLE-Mutated Endometrial Cancer: A Comprehensive Review.POLE 突变型子宫内膜癌的临床与病理特征:综述
Cancer Manag Res. 2024 Mar 4;16:117-125. doi: 10.2147/CMAR.S445055. eCollection 2024.
6
Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress.癌症突变集中在一组蛋白质复合物上,以预测对复制应激的抗性。
Cancer Discov. 2024 Mar 1;14(3):508-523. doi: 10.1158/2159-8290.CD-23-0641.
PLoS One. 2019 Mar 27;14(3):e0214318. doi: 10.1371/journal.pone.0214318. eCollection 2019.
4
A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme.一种在 DNA 聚合酶 ε 中反复出现的与癌症相关的取代会产生一种超活性酶。
Nat Commun. 2019 Jan 22;10(1):374. doi: 10.1038/s41467-018-08145-2.
5
High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.POLE 基因突变在同期子宫内膜癌和卵巢癌中的高频发生。
Hum Pathol. 2019 Mar;85:92-100. doi: 10.1016/j.humpath.2018.11.001. Epub 2018 Nov 15.
6
Eukaryotic DNA polymerases.真核生物 DNA 聚合酶。
Curr Opin Struct Biol. 2018 Dec;53:77-87. doi: 10.1016/j.sbi.2018.06.003. Epub 2018 Jul 10.
7
Comprehensive Characterization of Cancer Driver Genes and Mutations.全面描绘癌症驱动基因和突变。
Cell. 2018 Apr 5;173(2):371-385.e18. doi: 10.1016/j.cell.2018.02.060.
8
Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response.体细胞 POLE 外切酶结构域突变是散发性子宫内膜癌和结直肠癌发生的早期事件,决定了驱动突变景观、克隆性新生抗原负担和免疫反应。
J Pathol. 2018 Jul;245(3):283-296. doi: 10.1002/path.5081. Epub 2018 Apr 30.
9
Adjuvant Treatment for Proofreading Domain-Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues.校对域突变癌症的辅助治疗:对放疗、化疗和核苷类似物的敏感性。
Clin Cancer Res. 2018 Jul 1;24(13):3197-3203. doi: 10.1158/1078-0432.CCR-18-0266. Epub 2018 Mar 20.
10
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro.子宫肿瘤中的聚合酶ε(POLE)超突变与T淋巴细胞浸润以及体外对铂类化疗药物耐药性增加相关。
Gynecol Oncol. 2017 Jan;144(1):146-152. doi: 10.1016/j.ygyno.2016.11.023. Epub 2016 Nov 26.